Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study Article

sustainable development goals

publication date

  • November 1, 2019

webpage

published in

start page

  • 1518

end page

  • 1530

volume

  • 20

issue

  • 11